跳至主要内容
临床试验/NCT03254329
NCT03254329Unknown不适用

Establishing Global Reference Values for Human Milk Composition in a Multi-Center Collaborative Study

USDA, Western Human Nutrition Research Center4 个研究点 分布在 4 个国家目标入组 2,000 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
2,000
试验地点
4
主要终点
Change in vitamin and mineral concentrations in human breast milk

研究概览

简要总结

The primary purpose of the proposed research is to establish Reference Values (RVs) for micronutrients (MN) and macronutrients in human milk. The investigators' research to date has revealed highly variable milk MN concentrations among populations, and very low values in some low income countries (LICs) likely caused by poor maternal status and/or diet but RVs are needed to interpret these values. During the past year the investigators conducted a review of human milk nutrient composition, and formed a Technical Advisory Group (TAG) which developed the current proposal. Here, the investigators are conducting a longitudinal project on well-nourished women and infants. The Mothers, Infants and Lactation Quality (MILQ) study is a multi-center cohort project, investigating breast milk nutrient composition in well-nourished women across the first 8.5 months of lactation in four different populations. The countries involved are Denmark, Brazil, Bangladesh and The Gambia. Exclusive breastfeeding is an eligibility criterion up until the second post-partum study visit (between 1 - 3.4 months postpartum), with the exception of the first week after delivery. Other data collected on mothers and infants, including maternal and infant nutrient intake and status, morbidity, milk volume, and infant development, will inform interpretation and support application of the results. While the priority is to develop RVs for MN, other analyses will include human milk oligosaccharides (HMOs) and proteins, and free amino acids (FAA) in infant plasma. Thus, with the samples obtained the investigators will perform (a) laboratory analyses of milk, plasma and urine nutrients to construct RVs for global application, (b) analyses of HMOs and proteins in milk, and (c) metabolomic analysis of FAA and other metabolites in infant plasma. By request of the Bill and Melinda Gates Foundation (BMGF), colostrum and fecal microbiota samples will also be collected and stored for later analyses.

详细描述

The investigators will collect breast milk samples at four visits, at 2-3 days after birth (colostrum) and at 1-3.4, 3.5-5.9, and 6-8.5 months of lactation from well-nourished mothers age ≥18 to ≤40 years, in a systematic, identical way in four countries. The four sites are: Copenhagen, Denmark; Banjul, The Gambia; Rio de Janeiro, Brazil; and Mirpur, Dhaka, Bangladesh. The most important site selection criteria were that multiple micronutrient supplements are not consumed after week 28 of pregnancy; maternal diet is adequate but consumption of highly fortified foods is limited; and exclusive breastfeeding is 60% at 4 months.

In order to have 250 women and infants per site complete the study at 8.5 months, approximately 500 women will be recruited during the third trimester of pregnancy. This should allow for mothers and infants not meeting study eligibility criteria in pregnancy or early lactation, and drop-outs from the study. Recruitment during pregnancy will increase the opportunity to locate and recruit women since recruitment in the immediate post-delivery period will be difficult. It will also enable the women to be counselled on the importance of exclusive breastfeeding (EBF). Colostrum will be collected at 2-3 days postpartum for future analysis. The first collection of mature milk will occur between 1 and 3.4 months postpartum, when maternal and infant blood samples will also be collected on all participants. At the final two visits, in addition to milk collection, blood will be taken from all mothers but only half of the infants each time, primarily for the assessment of micronutrient status.

A requirement is that infants must be EBF in the 1-3.4 month period, and breastfed (BF) in the second and third period. Longitudinal measurements on the same mother after the BF period are not necessary for statistical reasons, as the investigators are not creating RVs for change in milk composition. The investigators expect that due to attrition and cessation of BF, the sample size will need to be augmented in later months; the alternative would have been to recruit and measure many more women in earlier stages in order to have an adequate sample size in the 7-8.5 month interval, which would be a much less efficient approach. Therefore after 6 months, if women are not breastfeeding, additional lactating women will be recruited from the group that was not EBF in the 3.4 month period, or from the local health center or community.

At all three points of mature milk collection the investigators will measure breast milk volume; diet, anthropometry and morbidity of the mother and infant; and infant development at 3.5-5.9 and 6 to 8.5 months; and will collect infant fecal samples for future analyses of the microbiome. Milk volume will be measured at three sites using the International Atomic Energy Agency's protocol that requires dosing the mother with deuterated water and collecting maternal and infant saliva urine samples at 0, 1, 2, 3, 4, 13 and 14 days after the dose. In Denmark breast milk volume will be measured by 24 hour infant weighing.

Most of the laboratory analyses will be conducted at the United States Department of Agriculture, Agricultural Research Service, Western Human Nutrition Research Center (WHNRC) in Davis, California. Other analyses will be performed in the Department of Chemistry at University of California, Davis (HMOs and other bioactive compounds in milk), and the Swiss Federal Institute of Technology in Zurich (iodine status). RVs will be constructed following the methods and principles developed for the World Health Organization (WHO) Child Growth Standards and the Intergrowth-21st Project.

研究设计

研究类型
Observational
观察模型
Family Based
时间视角
Prospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change in vitamin and mineral concentrations in human breast milk

时间窗: Breast milk samples collected 1-3.4, 3.5-5.9, and 6-8.5 months postpartum

To establish reference values, the vitamin and mineral concentrations will be measured in milk of well-nourished women

次要结局

  • Milk iodine(1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Maternal weight(1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Infant weight(1-3.4, 3.5-5.9, and 6-8.5 months)
  • Maternal height(1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Variation in other constituents of human breast milk(Breast milk samples collected at 1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Maternal and infant iodine status(1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Maternal nutrient intake(1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Infant dietary habits(1-3.4, 3.5-5.9, and 6-8.5 months)
  • Infant morbidity(1-3.4, 3.5-5.9, and 6-8.5 months)
  • Maternal lipid panel(Measured once at gestational week 28-30)
  • Micronutrient status of mothers and infants(Blood and urine samples surveyed at 1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Maternal nutrient intake during pregnancy(Measured during gestational week 35-37)
  • Maternal inflammatory markers(Measured once at gestational week 28-30)
  • Milk volume(1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Infant nutrient intake(1-3.4, 3.5-5.9, and 6-8.5 months)
  • Infant development(6-8.5 months)
  • Infant length(1-3.4, 3.5-5.9, and 6-8.5 months)
  • Maternal body mass index(1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Infant body composition(1-3.4, 3.5-5.9, and 6-8.5 months)
  • Change in infant microbiome(1-3.4, 3.5-5.9, and 6-8.5 months)
  • Change in maternal microbiome(Collected at gestational week 28-40, and 1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Maternal markers of insulin sensitivity(Measured once at gestational week 28-30)
  • Infant growth(1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Maternal body composition(1-3.4, 3.5-5.9, and 6-8.5 months postpartum)
  • Infant motor development(3.5-5.9 and 6-8.5 months)
  • Maternal Glucose Tolerance(Measured once at gestational week 28-30)
  • Maternal Hemoglobin A1c (HbA1c)(Measured once at gestational week 28-30)

研究者

发起方
USDA, Western Human Nutrition Research Center
申办方类型
Fed
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Establishing Global Reference Values for Human Milk | 临床试验